Tronox Reports Second Quarter 2015 Financial Results
Aug 4, 2015 - Press Releases
$0.70
including reducing our operating costs and working capital. In the second quarter, we signed a contract with a non-pigment company to sell high-quality ilmenite that we had previously stockpiled in a transaction that will produce cash of approximately
Casey continued: “Our TiO2 segment generated adjusted EBITDA of
The benefits of having Alkali in our portfolio are many, but its high cash generation is particularly valuable in this current period of depressed
Casey concluded: “With the cash generation strength of our operating businesses, coupled with our cash generation initiatives sourced from operating cost and working capital reductions, as well as capital expenditure reductions, we expect to generate positive free cash flow in 2016 after capital expenditures, interest expense and dividend payments. We intend to focus this cash surplus on deleveraging and providing for future growth of the company.”
Titanium Dioxide (
for CP titanium slag and rutile products declined. Zircon sales volumes remained at normal levels but were lower compared to very strong sales volumes in the year-ago quarter and selling prices declined modestly.
Compared sequentially,
lower. Selling prices for CP titanium slag increased 3 percent and rutile products remained level. Zircon sales increased 12 percent, driven by 18 percent higher sales volumes, partially offset by 5 percent lower selling prices.
We believe that because of oversupply conditions in the
inventories. If demand exceeds our forecasts over the balance of 2015, we have the operating flexibility to quickly increase production.
Capital expenditures of
With adjusted EBITDA of
Alkali
Alkali segment revenue of
Alkali adjusted EBITDA of
Corporate
Corporate adjusted EBITDA was
Consolidated
Selling, general and administrative expenses for the company in the second quarter were
Interest and debt expense of
Second Quarter 2015 Webcast Conference Call
Internet Broadcast: https://www.tronox.com/
Dial-in telephone numbers:
U.S. /
International: +1.253.237.1184
Conference ID: 94623862
Conference Call Presentation Slides: will be used during the conference call and are available on our website at https://www.tronox.com/
Webcast Conference Call Replay: available via the Internet and telephone beginning on
Internet Replay: www.tronox.com
Dial-in telephone numbers:
U.S. /
International: +1.404.537.3406
Conference ID: 94623862
Upcoming Conferences
During the third quarter a member of management is scheduled to present at the following conferences:
UBS Chemicals Conference ,New York ,September 9, 2015 RBC Capital Markets Global Industrial Conference ,Las Vegas ,September 10, 2015 Credit Suisse Basic Materials Conference ,New York ,September 17, 2015
Accompanying materials will be available at http://investor.tronox.com
About
Segment Information
The reportable segments presented herein represent the operating segments for which separate financial information is available and we utilize on a regular basis to assess performance, align strategies and allocate resources. Prior to the Alkali acquisition, we had two operating and reportable segments, Mineral Sands and Pigment, based on the way the management team was organized and we assessed performance, aligned strategies and allocated resources. As a result of the increased interdependency between the Mineral Sands and Pigment businesses and related organizational changes, we determined that it was better to review the Mineral Sands and Pigment businesses, along with our electrolytic business, as a combined one,
restructured our organization to reflect two integrated businesses,
Our
- exploration, mining and beneficiation of mineral sands deposits
- heavy mineral production of titanium feedstock (including chloride slag, slag fines and rutile), pig iron and zircon
- production and marketing of
TiO2 - electrolytic manganese dioxide manufacturing and marketing
Our Alkali operating segment includes:
- exploration, mining and beneficiation of trona ore
- production and marketing of natural soda ash and its derivatives: sodium bicarbonate, sodium sesquicarbonate and caustic soda
Segment performance is evaluated based on segment operating profit (loss), which represents the results of segment operations before unallocated costs, such as general corporate expenses not identified to a specific segment, interest expense, other income (expense) and income tax expense or benefit.
Forward Looking Statements
Statements in this release that are not historical are forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements, which are subject to known and unknown risks, uncertainties and assumptions about us, may include projections of our future financial performance based on our growth strategies and anticipated trends in our business. These statements are only predictions based on our current expectations and projections about future events. There are important factors that could cause our actual results, level of activity, performance or achievements to differ materially from the results, level of activity, performance or achievements expressed or implied by the forward-looking statements. These and other risk factors are discussed in the company’s filings with the
Commission
Moreover, we operate in a very competitive and rapidly changing environment. New risks and uncertainties emerge from time to time, and it is not possible for our management to predict all risks and uncertainties, nor can management assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. Although we believe the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, level of activity, performance or achievements. Neither we nor any other person assumes responsibility for the accuracy or completeness of any of these forward-looking statements. You should not rely upon forward-looking statements as predictions of future events. Unless otherwise required by applicable laws, we
undertake no obligation to update or revise any forward-looking statements, whether as a result of new information or future developments.
Use of Non-U.S. GAAP Financial Information
To provide investors and others with additional information regarding
performance by excluding certain costs and expenses that the company believes are not indicative of its core operating results. The presentation of these non-U.S. GAAP financial measures are not meant to be considered in isolation or as a substitute for results or guidance prepared and presented in accordance with U.S. GAAP. A reconciliation of the non-U.S. GAAP financial measures to U.S. GAAP results is included herein.
Management believes these non-U.S. GAAP financial measures:
Reflect Tronox Limited’s ongoing business in a manner that allows for meaningful period-to-period comparison and analysis of trends in its business, as they exclude income and expense that are not reflective of ongoing operating results;- Provide useful information to investors and others in understanding and evaluating
Tronox Limited’s operating results and future prospects in the same manner as management and in comparing financial results across accounting periods; - Provide additional view of the operating performance of the company by adding interest expenses, taxes, depreciation, depletion and amortization to the net income. Further adjustments due to purchase accounting and stock-based compensation charges attempt to exclude items that are either non-cash or unusual in nature;
- Assist investors to assess the company’s compliance with financial covenants under its debt instruments;
- Adjusted EBITDA is one of the primary measures management uses for planning and budgeting processes and to monitor and evaluate financial and operating results. Adjusted EBITDA is not a recognized term under U.S. GAAP and does not purport to be an alternative to measures of our financial performance as determined in accordance with U.S. GAAP, such as net income (loss). Because other companies may calculate EBITDA and Adjusted EBITDA differently than
Tronox , EBITDA may not be, and Adjusted EBITDA as presented in this release is not, comparable to similarly titled measures reported by other companies, and - We believe that the non-U.S. GAAP financial measure “Adjusted net loss attributable to
Tronox Limited ” and its presentation on a per share basis provide useful information about our operating results to investors and securities analysts. We also believe that excluding the effects of these items from operating results allows management and investors to compare more easily the financial performance of our underlying businesses from period to period.
Media Contact:
Investor Contact:
|
|||||||||||||
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (US GAAP) |
|||||||||||||
(UNAUDITED) |
|||||||||||||
(Millions of U.S. dollars, except share and per share data) |
|||||||||||||
Three Months Ended |
Six Months Ended |
||||||||||||
2015 |
2014 |
2015 |
2014 |
||||||||||
Net sales |
$ 617 |
$ 490 |
$ 1,002 |
$ 908 |
|||||||||
Cost of goods sold |
593 |
430 |
943 |
823 |
|||||||||
Gross profit |
24 |
60 |
59 |
85 |
|||||||||
Selling, general, and administrative expenses |
(72) |
(45) |
(116) |
(91) |
|||||||||
Restructuring expense |
(2) |
– |
(2) |
– |
|||||||||
Income (loss) from operations |
(50) |
15 |
(59) |
(6) |
|||||||||
Interest and debt expense, net |
(52) |
(33) |
(86) |
(67) |
|||||||||
Loss on extinguishment of debt |
– |
(8) |
– |
(8) |
|||||||||
Other income (expense), net |
(5) |
3 |
(1) |
3 |
|||||||||
Loss before income taxes |
(107) |
(23) |
(146) |
(78) |
|||||||||
Income tax benefit (provision) |
(11) |
25 |
(18) |
26 |
|||||||||
Net income (loss) |
(118) |
2 |
(164) |
(52) |
|||||||||
Net income attributable to noncontrolling interest |
1 |
2 |
4 |
6 |
|||||||||
Net loss attributable to |
$ (119) |
$ – |
$ (168) |
$ (58) |
|||||||||
Loss per share, basic and diluted |
$ (1.03) |
$ – |
$ (1.45) |
$ (0.51) |
|||||||||
Weighted average shares outstanding, basic and diluted (in thousands) |
115,569 |
113,962 |
115,472 |
113,770 |
|||||||||
Other Operating Data: |
|||||||||||||
Capital expenditures |
$ 61 |
$ 43 |
$ 93 |
$ 67 |
|||||||||
Depreciation, depletion and amortization expense |
$ 75 |
$ 84 |
$ 140 |
$ 157 |
|
|||||||||||||||
SCHEDULE OF ADJUSTED EARNINGS (NON-U.S. GAAP)* |
|||||||||||||||
(UNAUDITED) |
|||||||||||||||
(Millions of U.S. dollars, except share and per share data) |
|||||||||||||||
Three Months Ended |
Six Months Ended |
||||||||||||||
2015 |
2014 |
2015 |
2014 |
||||||||||||
Net sales |
$ 617 |
$ 490 |
$ 1,002 |
$ 908 |
|||||||||||
Cost of goods sold |
584 |
430 |
934 |
823 |
|||||||||||
Gross profit |
33 |
60 |
68 |
85 |
|||||||||||
Selling, general, and administrative expenses |
(53) |
(45) |
(99) |
(91) |
|||||||||||
Adjusted income (loss) from operations |
(20) |
15 |
(31) |
(6) |
|||||||||||
Interest and debt expense, net |
(44) |
(33) |
(78) |
(67) |
|||||||||||
Loss on extinguishment of debt |
– |
(8) |
– |
(8) |
|||||||||||
Other income, net |
(5) |
3 |
(1) |
3 |
|||||||||||
Adjusted income (loss) before income taxes |
(69) |
(23) |
(110) |
(78) |
|||||||||||
Income tax benefit (provision) |
(11) |
25 |
(18) |
26 |
|||||||||||
Adjusted net income (loss) |
(80) |
2 |
(128) |
(52) |
|||||||||||
Net income attributable to noncontrolling interest |
1 |
2 |
4 |
6 |
|||||||||||
Adjusted net income (loss) attributable to |
$ (81) |
$ – |
$ (132) |
$ (58) |
|||||||||||
Diluted adjusted loss per share, attributable to |
$ (0.70) |
$ – |
$ (1.14) |
$ (0.51) |
|||||||||||
Weighted average shares outstanding, diluted (in thousands) |
115,569 |
113,962 |
115,472 |
113,770 |
|||||||||||
* We believe that the non-U.S. GAAP financial measure “Adjusted net income (loss) attributable to |
|
||||||||
RECONCILIATION OF NON-U.S. GAAP FINANCIAL MEASURES |
||||||||
(UNAUDITED) |
||||||||
(Millions of U.S. dollars, except share and per share data) |
||||||||
RECONCILIATION OF NET LOSS |
||||||||
ATTRIBUTABLE TO TRONOX LIMITED (U.S. GAAP) |
||||||||
TO ADJUSTED NET LOSS |
||||||||
ATTRIBUTABLE TO TRONOX LIMITED (NON-U.S. GAAP) |
||||||||
Three Months Ended |
Six Months Ended |
|||||||
2015 |
2014 |
2015 |
2014 |
|||||
Net loss attributable to |
$ (119) |
$ – |
$ (168) |
$ (58) |
||||
Acquisition related expense (a) |
36 |
– |
34 |
– |
||||
Restructuring expense (b) |
2 |
– |
2 |
– |
||||
Adjusted net income (loss) attributable to |
$ (81) |
$ – |
$ (132) |
$ (58) |
||||
Diluted loss per share attributable to |
$ (1.03) |
$ – |
$ (1.45) |
$ (0.51) |
||||
Acquisition related expense, per diluted share |
0.31 |
– |
0.29 |
– |
||||
Restructuring expense, per diluted share |
0.02 |
– |
0.02 |
– |
||||
Diluted adjusted income (loss) per share attributable to |
$ (0.70) |
$ – |
$ (1.14) |
$ (0.51) |
||||
Weighted average shares outstanding, diluted (in thousands) |
115,569 |
113,962 |
115,472 |
113,770 |
||||
(a) One-time non-operating items and the effect of acquisitions. |
|||||
(b) Represents severance costs associated with the shutdown of our sodium chlorate plant. |
|
||||||||
SEGMENT INFORMATION |
||||||||
(UNAUDITED) |
||||||||
(Millions of U.S. dollars) |
||||||||
Three Months Ended |
Six Months Ended |
|||||||
2015 |
2014 |
2015 |
2014 |
|||||
Sales |
||||||||
TiO2 segment |
$ 409 |
|
$ 794 |
|
||||
Alkali segment |
208 |
– |
208 |
– |
||||
Net sales |
$ 617 |
|
|
|
||||
Income (loss) from operations |
||||||||
TiO2 segment |
$ (41) |
$ 30 |
$ (32) |
$ 26 |
||||
Alkali segment |
25 |
– |
25 |
– |
||||
Corporate |
(34) |
(15) |
(52) |
(32) |
||||
Income (loss) from operations |
(50) |
15 |
(59) |
(6) |
||||
Interest and debt expense, net |
(52) |
(33) |
(86) |
(67) |
||||
Loss on extinguishment of debt |
– |
(8) |
– |
(8) |
||||
Other income (expense), net |
(5) |
3 |
(1) |
3 |
||||
Loss before income taxes |
(107) |
(23) |
(146) |
(78) |
||||
Income tax benefit (provision) |
(11) |
25 |
(18) |
26 |
||||
Net income (loss) |
(118) |
2 |
(164) |
(52) |
||||
Net income attributable to noncontrolling interest |
1 |
2 |
4 |
6 |
||||
Net income (loss) attributable to |
|
$ – |
$ (168) |
$ (58) |
|
||||||||
CONDENSED CONSOLIDATED BALANCE SHEETS |
||||||||
(UNAUDITED) |
||||||||
(Millions of U.S. dollars, except share and per share data) |
||||||||
|
|
|||||||
ASSETS |
2015 |
2014 |
||||||
Current Assets |
||||||||
Cash and cash equivalents |
$ 205 |
$ 1,276 |
||||||
Restricted cash |
5 |
3 |
||||||
Accounts receivable, net of allowance for doubtful accounts |
472 |
277 |
||||||
Inventories, net |
780 |
770 |
||||||
Prepaid and other assets |
60 |
42 |
||||||
Deferred tax assets |
10 |
13 |
||||||
Total current assets |
1,532 |
2,381 |
||||||
Noncurrent Assets |
||||||||
Property, plant and equipment, net |
1,967 |
1,227 |
||||||
Mineral leaseholds, net |
1,736 |
1,058 |
||||||
Intangible assets, net |
260 |
272 |
||||||
Inventories, net |
14 |
57 |
||||||
Long-term deferred tax assets |
8 |
9 |
||||||
Other long-term assets |
75 |
61 |
||||||
Total assets |
$ 5,592 |
$ 5,065 |
||||||
LIABILITIES AND EQUITY |
||||||||
Current Liabilities |
||||||||
Accounts payable |
$ 203 |
$ 160 |
||||||
Accrued liabilities |
156 |
147 |
||||||
Short-term debt |
150 |
– |
||||||
Long-term debt due within one year |
17 |
18 |
||||||
Income taxes payable |
26 |
32 |
||||||
Deferred tax liabilities |
8 |
9 |
||||||
Total current liabilities |
560 |
366 |
||||||
Noncurrent Liabilities |
||||||||
Long-term debt |
2,967 |
2,375 |
||||||
Pension and postretirement healthcare benefits |
168 |
172 |
||||||
Asset retirement obligations |
82 |
85 |
||||||
Long-term deferred tax liabilities |
190 |
204 |
||||||
Other long-term liabilities |
96 |
75 |
||||||
Total liabilities |
4,063 |
3,277 |
||||||
Shareholders’ Equity |
||||||||
Tronox Limited Class A ordinary shares, par value |
1 |
1 |
||||||
Tronox Limited Class B ordinary shares, par value |
– |
– |
||||||
Capital in excess of par value |
1,490 |
1,476 |
||||||
Retained earnings |
302 |
529 |
||||||
Accumulated other comprehensive loss |
(432) |
(396) |
||||||
Total shareholders’ equity |
1,361 |
1,610 |
||||||
Noncontrolling interest |
168 |
178 |
||||||
Total equity |
1,529 |
1,788 |
||||||
Total liabilities and equity |
$ 5,592 |
$ 5,065 |
||||||
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS |
|||
(UNAUDITED) |
|||
(Millions of U.S. dollars) |
|||
Six Months Ended |
|||
2015 |
2014 |
||
Cash Flows from Operating Activities: |
|||
Net loss |
|
$ (52) |
|
Adjustments to reconcile net loss to net cash provided by operating activities: |
|||
Depreciation, depletion and amortization |
140 |
157 |
|
Deferred income taxes |
(2) |
(45) |
|
Share-based compensation expense |
13 |
11 |
|
Amortization of deferred debt issuance costs and discount on debt |
5 |
5 |
|
Pension and postretirement healthcare benefit expense |
1 |
3 |
|
Loss on extinguishment of debt |
– |
8 |
|
Other noncash items affecting net loss |
14 |
11 |
|
Contributions to employee pension and postretirement plans |
(8) |
(7) |
|
Changes in assets and liabilities: |
|||
Increase in accounts receivable |
(52) |
(64) |
|
Decrease in inventories |
53 |
2 |
|
(Increase) decrease in prepaid and other assets |
7 |
8 |
|
Increase (decrease) in accounts payable and accrued liabilities |
1 |
(10) |
|
Increase (decrease) in income taxes payable |
4 |
9 |
|
Other, net |
1 |
(1) |
|
Cash provided by operating activities |
13 |
35 |
|
Cash Flows from Investing Activities: |
|||
Capital expenditures |
(93) |
(67) |
|
Acquisition of business |
(1,653) |
– |
|
Cash used in investing activities |
(1,746) |
(67) |
|
Cash Flows from Financing Activities: |
|||
Repayments of debt |
(9) |
(11) |
|
Proceeds from debt |
750 |
– |
|
Debt issuance costs |
(15) |
(2) |
|
Dividends paid |
(59) |
(58) |
|
Proceeds from the exercise of warrants and options |
3 |
2 |
|
Cash provided by (used in) financing activities |
670 |
(69) |
|
Effects of exchange rate changes on cash and cash equivalents |
(8) |
(2) |
|
Net increase (decrease) in cash and cash equivalents |
(1,071) |
(103) |
|
Cash and cash equivalents at beginning of period |
1,276 |
1,475 |
|
Cash and cash equivalents at end of period |
$ 205 |
|
|
|
||||||||
RECONCILIATION OF NET LOSS TO EBITDA AND ADJUSTED EBITDA (NON-U.S. GAAP) |
||||||||
(UNAUDITED) |
||||||||
(Millions of U.S. dollars) |
||||||||
Three Months Ended |
Six Months Ended |
|||||||
2015 |
2014 |
2015 |
2014 |
|||||
Net income (loss) |
$ (118) |
$ 2 |
$ (164) |
$ (52) |
||||
Interest and debt expense, net |
52 |
33 |
86 |
67 |
||||
Interest income |
(2) |
(3) |
(4) |
(6) |
||||
Income tax (benefit) provision |
11 |
(25) |
18 |
(26) |
||||
Depreciation, depletion and amortization expense |
75 |
84 |
140 |
157 |
||||
EBITDA |
18 |
91 |
76 |
140 |
||||
Amortization of inventory step-up from purchase accounting |
9 |
– |
9 |
– |
||||
Transfer tax due to acquisition |
(3) |
– |
(11) |
– |
||||
Transaction cost (a) |
21 |
– |
27 |
– |
||||
Share-based compensation |
7 |
6 |
13 |
11 |
||||
Loss on extinguishment of debt |
– |
8 |
– |
8 |
||||
Foreign currency remeasurement |
5 |
(2) |
5 |
4 |
||||
Other items (b) |
10 |
5 |
12 |
9 |
||||
Adjusted EBITDA |
$ 67 |
$ 108 |
$ 131 |
$ 172 |
||||
Adjusted EBITDA by Segment |
||||||||
Tio2 segment |
$ 36 |
$ 125 |
$ 121 |
$ 208 |
||||
Alkali segment |
50 |
– |
50 |
– |
||||
Corporate |
(19) |
(17) |
(40) |
(36) |
||||
$ 67 |
$ 108 |
$ 131 |
$ 172 |
|||||
(a) |
During 2015, transaction costs consist of costs associated with the acquisition of the Alkali business, including banking fees, legal and professional fees. |
|||||
(b) |
Includes noncash pension and postretirement costs, accretion expense, severance expense, and other items. |
Logo – http://photos.prnewswire.com/prnh/20131106/DA11850LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/tronox-reports-second-quarter-2015-financial-results-300123703.html
SOURCE
News Provided by Acquire Media